{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_0", "document_index": 69, "latency_s": 13.085076499992283, "prompt_toks": 5186, "completion_toks": 74}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Buprenorphine\n\nSkull and crossbones darktextred2.png\n\nFatal overdose may occur when opiates are combined with other depressants such as benzodiazepines, barbiturates, gabapentinoids, thienodiazepines, alcohol or other GABAergic substances.[1]\n\nIt is strongly discouraged to combine these substances, particularly in common to heavy doses.\n\nSummary sheet: Buprenorphine\n\nBuprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n\n                    Context: \n                    This chunk appears at the beginning of the document, introducing buprenorphine with a prominent overdose warning about combining it with other depressants, followed by a summary of its chemical class and pharmacological action as a partial opioid agonist. It sets the stage for the detailed sections on effects, dosages, pharmacology, and harm reduction found later in the page.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_1", "document_index": 69, "latency_s": 11.807103300001472, "prompt_toks": 5400, "completion_toks": 100}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Buprenorphine  Purpose Chemical Nomenclature Common names Buprenex, Subutex, Butrans, Cizdol, Addnok, Transtec Systematic name (2S)-2-[(5R,6R,7R,14S)-9α-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy-6-methoxymorphinan-7-yl]-3,3-dimethylbutan-2-ol Class Membership Psychoactive class Opioid Chemical class Morphinan Routes of Administration WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section . ⇣ Sublingual Dosage Bioavailability 30% [2] Threshold <=0.3 mg Light 1 - 2 mg Common 2 - 4 mg Strong 4 - 8 mg Heavy 8mg + Duration Total 18 - 24 hours Onset 40 - 80 minutes Peak 1.5 - 2 hours After effects 1 - 3 days ⇣ Insufflated Dosage Bioavailability 48% [3] Threshold < 0.2 mg Light 0.2 - 0.4 mg Common 0.4 - 0.8 mg Strong 0.8 - 1.5 mg Heavy 1.5 mg + Duration Total 8 - 14 hours Onset 30 - 60 minutes Peak 4 - 8 hours After effects 1 - 3 days DISCLAIMER : PW's dosage information is\n\n\n                    Context: \n                    This chunk details the chemical nomenclature, common names, class membership, and routes of administration for buprenorphine, including specific dosage guidelines, bioavailability, onset, duration, and strength categorizations for sublingual and insufflated use. It is part of the document's introductory summary and infobox, providing essential reference data on the drug’s identity and safe usage parameters before the more comprehensive discussions of effects, pharmacology, harm potential, and legal status found in later sections.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_2", "document_index": 69, "latency_s": 9.27637279999908, "prompt_toks": 5200, "completion_toks": 79}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    0.2 - 0.4 mg Common 0.4 - 0.8 mg Strong 0.8 - 1.5 mg Heavy 1.5 mg + Duration Total 8 - 14 hours Onset 30 - 60 minutes Peak 4 - 8 hours After effects 1 - 3 days DISCLAIMER : PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy. Interactions MAOIs Nitrous PCP Stimulants Alcohol Benzodiazepines DXM GHB GBL Ketamine MXE Tramadol Grapefruit\n\n\n                    Context: \n                    This chunk provides specific dosage guidelines, duration, onset, and peak effects for insufflated (nasal) buprenorphine use, followed by a disclaimer emphasizing educational use of the information and a list of substances with known interactions. It is part of a broader section detailing routes of administration, dosage ranges, durations, and interactions for buprenorphine within the full drug profile.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_3", "document_index": 69, "latency_s": 9.503515500022331, "prompt_toks": 5303, "completion_toks": 78}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    At higher dosages, it is used to treat opioid addiction in opioid-dependent individuals. In lower dosages it is used to control moderate-acute pain in non-opioid-tolerant individuals and in even lower dosages it is used to control moderate chronic pain.\n\nBuprenorphine was patented in 1965, and approved for medical use in the United States in 1981.[4] In 2017, 14.6 million prescriptions for the medication were written in the United States.[5] It is also a common medication used to treat opioid use disorders, such as addiction to heroin.[5] Buprenorphine may also be used recreationally by injection or intranasally for the high it produces.[5]\n\nContents\n\n1 Chemistry\n\n2 Pharmacology\n\n3 Subjective effects\n\n3.1 Physical effects\n\n3.2 Cognitive effects\n\n3.3 Visual effects\n\n3.3.1 Hallucinatory states\n\n3.4 Experience reports\n\n4 Toxicity and harm potential\n\n4.1 Tolerance and addiction potential\n\n4.2 Precipitated withdrawal syndrome\n\n4.3 Dangerous interactions\n\n5 Legal status\n\n6 See also\n\n\n                    Context: \n                    This chunk appears near the beginning of the document, following the summary and warnings, and provides an overview of the primary medical uses, history, and prevalence of buprenorphine, as well as noting its potential for recreational use. It directly precedes the table of contents and sets the stage for later detailed sections on chemistry, pharmacology, effects, harm potential, and legal status.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_4", "document_index": 69, "latency_s": 11.827801600011298, "prompt_toks": 5256, "completion_toks": 86}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    3.4 Experience reports\n\n4 Toxicity and harm potential\n\n4.1 Tolerance and addiction potential\n\n4.2 Precipitated withdrawal syndrome\n\n4.3 Dangerous interactions\n\n5 Legal status\n\n6 See also\n\n7 External links\n\n8 References\n\nChemistry\n\nBuprenorphine is a semi-synthetic morphinan derivative of the opioid alkaloid thebaine. Like many opioids, such as codeine or hydrocodone, it is has a morphinan backbone.\n\nBuprenorphine and other molecules of this class contain a polycyclic core of three benzene rings fused in a zig-zag pattern called phenanthrene. A fourth nitrogen containing ring is fused to the phenanthrene at R9 and R13. Buprenophine (along with other morphinans) contains an ether bridge between two of its rings, connecting the benzene and opposite cyclohexane ring through an oxygen group.\n\n\n                    Context: \n                    This chunk appears at the transition between sections detailing the subjective effects of buprenorphine and the in-depth discussions of its toxicity, harm potential, mechanisms of tolerance and withdrawal, dangerous drug interactions, and legal status. It also marks the start of the chemistry section, which describes the molecular structure and classification of buprenorphine within the document's comprehensive coverage of its pharmacological, experiential, and legal aspects.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_5", "document_index": 69, "latency_s": 9.638185299991164, "prompt_toks": 5226, "completion_toks": 90}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Buprenorphine is unique to human medical opioids as it contains an addition fused ring which connects to the lower cyclohexane ring at R6 and R14. This structure is called a endoethenotetrahydrooripavine backbone, often found in veterinarian opioids. It contains a hydroxy group (OH-) substituted on the benzene ring and a methoxy group bound to the lower cyclohexane ring. The backbone of buprenorphine is also substituted with a methyl cyclopropyl moeity on its amino group. Adjacent to its methoxy attachment, the cyclohexane ring is bonded to R2 of a 2-butanol chain.\n\nPharmacology\n\nThis pharmacology section is incomplete. You can help by adding to it.\n\n\n                    Context: \n                    This chunk appears in the \"Chemistry\" section of the buprenorphine article, providing detailed information about the molecule’s unique structural features—specifically its endoethenotetrahydrooripavine backbone and ring system, which distinguishes it from other opioids used in human medicine. It immediately precedes the \"Pharmacology\" section, which covers how buprenorphine interacts with opioid receptors in the body.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_6", "document_index": 69, "latency_s": 9.568933600006858, "prompt_toks": 5260, "completion_toks": 103}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Pharmacology\n\nThis pharmacology section is incomplete. You can help by adding to it.\n\nBuprenorphine acts as a partial agonist of the μ-opioid receptor with a binding affinity of Ki = 1.5 nM in contrast to full agonists like morphine. It also acts as an antagonist of the κ-opioid receptor with a binding affinity of Ki = 2.5 nM and the δ-opioid receptor with a binding affinity of Ki = 6.1 nM. The ratio of these binding affinities is important, if you compare morphine's binding ratio of 1:50:176 to Buprenorphine's ratio of 15:25:61, it is apparent that the side-effect profile will be much higher to Buprenorphine and μ-opioid stimulation for euphoric effects, sequentially the drug will also bind to delta and kappa opioid receptors to a comparatively high degree.\n\n\n                    Context: \n                    This chunk appears in the \"Pharmacology\" section of the Buprenorphine article, following the \"Chemistry\" section and preceding \"Subjective effects.\" It details buprenorphine's mechanism of action on opioid receptors, emphasizing its role as a partial agonist at the μ-opioid receptor and antagonist at κ- and δ-opioid receptors, and discusses binding affinities and comparative side-effect profiles, providing foundational information on how the drug produces its clinical and psychoactive effects.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_7", "document_index": 69, "latency_s": 10.991783399978885, "prompt_toks": 5239, "completion_toks": 108}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Buprenorphine exerts its effects by binding to and activating the μ-opioid receptor. This occurs because opioids structurally mimic endogenous endorphins which are naturally found within the body and also work upon the μ-opioid receptor set. The way in which opioids structurally mimic these natural endorphins results in their euphoria, pain relief and anxiolytic effects. This is because endorphins are responsible for reducing pain, causing sleepiness, and feelings of pleasure. They can be released in response to pain, strenuous exercise, orgasm, or general excitement.\n\nSubjective effects\n\nDisclaimer: The effects listed below cite the Subjective Effect Index (SEI), an open research literature based on anecdotal user reports and the personal analyses of PsychonautWiki contributors. As a result, they should be viewed with a healthy degree of skepticism.\n\n\n                    Context: \n                    This chunk appears within the \"Pharmacology\" section of the Buprenorphine page, following an explanation of buprenorphine’s receptor binding properties and preceding the \"Subjective effects\" section. It describes the mechanism by which buprenorphine, like other opioids, mimics endorphins to activate μ-opioid receptors, resulting in effects such as euphoria, pain relief, and anxiolysis, thereby bridging the scientific pharmacology content and user-reported subjective experiences detailed later in the document.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_8", "document_index": 69, "latency_s": 10.173309400008293, "prompt_toks": 5266, "completion_toks": 74}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    It is also worth noting that these effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects. Likewise, adverse effects become increasingly likely with higher doses and may include addiction, severe injury, or death ☠.\n\nPhysical effects\n\nPain relief\n\nPhysical euphoria - This particular substance can be considered as less intense in its physical euphoria when compared with that of morphine or diacetylmorphine (heroin) due to it being a partial agonist of the μ-opioid receptor. The sensation itself can be described as extreme feelings of intense physical comfort, warmth and bliss which spreads throughout the body.\n\nItchiness\n\nRespiratory depression - Buprenorphine causes less respiratory depression than other opioids due to it being a partial agonist of the μ-opioid receptor.\n\nDizziness\n\nSedation\n\nDecreased heart rate\n\nConstipation\n\nCough suppression\n\nDecreased libido\n\nDifficulty urinating\n\n\n                    Context: \n                    This chunk is from the \"Subjective effects\" section of the Buprenorphine page, specifically detailing the range of possible physical effects experienced by users, such as pain relief, euphoria, respiratory depression, sedation, and other bodily responses. It follows a disclaimer about the variability and risks of these effects, and precedes sections on cognitive and visual effects.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_9", "document_index": 69, "latency_s": 10.564145799988182, "prompt_toks": 5265, "completion_toks": 76}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Dizziness\n\nSedation\n\nDecreased heart rate\n\nConstipation\n\nCough suppression\n\nDecreased libido\n\nDifficulty urinating\n\nPupil constriction\n\nNausea - Buprenorphine causes substantially more nausea and vomiting than other opioids.\n\nAppetite suppression\n\nOrgasm suppression\n\nCognitive effects\n\nThe general head space of buprenorphine is described by many as one of euphoria, relaxation, anxiety suppression and pain relief.\n\nCognitive euphoria - This particular substance can be considered as less intense in its cognitive euphoria when compared with that of morphine or diacetylmorphine (heroin) due to it being a partial agonist of the μ-opioid receptor. It is still, however, capable of extreme intensity and overwhelming bliss at heavier dosages with a low tolerance. The sensation itself can be described as powerful and overwhelming feeling of emotional bliss, contentment, and happiness.\n\nAnxiety suppression\n\nVisual effects\n\nHallucinatory states\n\n\n                    Context: \n                    This chunk appears in the \"Subjective effects\" section of the Buprenorphine page, specifically listing the physical and cognitive effects experienced by users, followed by an introduction to visual effects and hallucinatory states. It provides detailed descriptions of side effects such as sedation, nausea, and euphoria, contextualizing how buprenorphine affects the body and mind.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_10", "document_index": 69, "latency_s": 10.227725700009614, "prompt_toks": 5267, "completion_toks": 73}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Anxiety suppression\n\nVisual effects\n\nHallucinatory states\n\nInternal hallucination - One may experience a state of semi-consciousness and hypnagogia during heavy dosage nodding which results in dream-like states and up to level 3 imagery. This is often accompanied by ill-defined geometry.\n\nExperience reports\n\nThere are currently no anecdotal reports which describe the effects of this compound within our experience index. Additional experience reports can be found here:\n\nErowid Experience Vaults: Buprenorphine\n\nToxicity and harm potential\n\nTable from the 2010 ISCD study ranking various drugs (legal and illegal) based on statements by drug-harm experts. Buprenorphine was found to be the 19th overall most dangerous drug.[6]\n\nA 2007 assessment of harm from recreational drug use (mean physical harm and mean dependence liability): Buprenorphine was ranked 9th in dependence, 8th in physical harm, and 11th in social harm.[7]\n\n\n                    Context: \n                    This chunk is from the section detailing buprenorphine's subjective effects, specifically addressing cognitive and visual effects such as anxiety suppression and hallucinatory states, followed by references to subjective experience reports. It then transitions into the toxicity and harm potential of buprenorphine, including its relative ranking among other drugs for danger, dependence, physical and social harm.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_11", "document_index": 69, "latency_s": 10.319360199995572, "prompt_toks": 5235, "completion_toks": 93}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    A 2007 assessment of harm from recreational drug use (mean physical harm and mean dependence liability): Buprenorphine was ranked 9th in dependence, 8th in physical harm, and 11th in social harm.[7]\n\nBuprenorphine has a low toxicity relative to dose: the ceiling dose for buprenorphine is usually between 16mg and 32mg, and anything above this will not produce an increase in respiratory depression (the primary cause of death in opioid overdose is severe respiratory depression, leading to respiratory collapse). Thus increasing the dose of buprenorphine above this level will not continue to increase risk of death in a fashion similar to other μ-opioid receptor agonists. As with all opioids, long-term effects can vary but can include diminished libido, apathy and memory loss.\n\n\n                    Context: \n                    This excerpt is from the \"Toxicity and harm potential\" section of the Buprenorphine drug profile, which discusses its ranking in terms of dependence, physical harm, and social harm compared to other recreational drugs. It highlights buprenorphine's relatively low toxicity, its dose ceiling for respiratory depression, and potential long-term side effects, providing important context for understanding its safety profile within the larger discussion of risks and harm reduction associated with opioid use.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_12", "document_index": 69, "latency_s": 11.334804599988274, "prompt_toks": 5249, "completion_toks": 92}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Regardless of the ceiling dose, an important distinction has to be made in the dose used in opioid naive individuals and opioid experienced individuals. Even low doses in individuals with no tolerance can cause unpleasant side-effects like dizziness, loss of balance, and vomiting. Because of the long half-life of buprenorphine, these side-effects can last a long while in opioid naive individuals which creates the risk of severe dehydration from uncontrollable vomiting.\n\nBuprenorphine is often sold under the brand name Suboxone, which also contains naloxone. Naloxone is not orally active except at higher doses, so when large amounts of Suboxone are taken, the naloxone takes effect and reverses the effects of the buprenorphine. This is done to deter abuse of Suboxone.\n\nIt is strongly recommended that one use harm reduction practices when using this drug.\n\nTolerance and addiction potential\n\n\n                    Context: \n                    This section appears within the \"Toxicity and harm potential\" part of the buprenorphine article, highlighting the dangers of buprenorphine in opioid-naive individuals, the long-lasting adverse effects due to its long half-life, and risks of severe dehydration. It explains abuse-deterrence in Suboxone formulations via naloxone and concludes with a general harm reduction recommendation, directly preceding the \"Tolerance and addiction potential\" subsection.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_13", "document_index": 69, "latency_s": 9.20922150000115, "prompt_toks": 5140, "completion_toks": 71}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    It is strongly recommended that one use harm reduction practices when using this drug.\n\nTolerance and addiction potential\n\nAs with other opioids, the chronic use of buprenorphine can be considered moderately addictive with a high potential for abuse and is capable of causing psychological dependence among certain users. When addiction has developed, cravings and withdrawal symptoms may occur if a person suddenly stops their usage.\n\n\n                    Context: \n                    This passage appears in the \"Toxicity and harm potential\" section of the buprenorphine drug profile. It introduces the topics of tolerance and addiction, detailing buprenorphine's moderate addictive potential and the risk of dependence and withdrawal with chronic use, as part of a broader discussion on the safe use and risks associated with the drug.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_14", "document_index": 69, "latency_s": 10.61449619999621, "prompt_toks": 5208, "completion_toks": 98}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Tolerance to many of the effects of buprenorphine develops with prolonged and repeated use. The rate at which this occurs develops at different rates for different effects, with tolerance to the constipation-inducing effects developing particularly slowly for instance. This results in users having to administer increasingly large doses to achieve the same effects. After that, it takes about 3 - 7 days for the tolerance to be reduced to half and 1 - 2 weeks to be back at baseline (in the absence of further consumption). Buprenorphine presents cross-tolerance with all other opioids, meaning that after the consumption of buprenorphine all opioids will have a reduced effect.\n\nPrecipitated withdrawal syndrome\n\n\n                    Context: \n                    This chunk appears in the \"Tolerance and addiction potential\" section of the Buprenorphine entry, following a discussion of the drug's moderate addictiveness and abuse potential. It explains how tolerance to buprenorphine's effects develops with repeated use, including cross-tolerance with other opioids and typical timelines for tolerance to diminish. The section then transitions into \"Precipitated withdrawal syndrome,\" which addresses buprenorphine's potential to trigger withdrawal symptoms in opioid-dependent individuals.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_15", "document_index": 69, "latency_s": 10.18896249998943, "prompt_toks": 5235, "completion_toks": 75}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Precipitated withdrawal syndrome\n\nBuprenorphine has the ability to precipitate withdrawal symptoms in opiate-dependent individuals. This is due to buprenorphine only being a partial agonist, which does not activate the receptor with the appreciable efficacy of a full agonist, as well as having a very high binding affinity for the μ-opioid receptor (Ki = 1.5nM), displacing other agonists that may still be attached when the buprenorphine is ingested.\n\nNote: It is a common misconception that naloxone, in some buprenorphine formulations, is what causes the precipitated withdrawal syndrome to manifest. This is false, as naloxone has a lower binding than Buprenorphine, as well as being inactive through most routes of administration.\n\nDangerous interactions\n\n\n                    Context: \n                    This section explains how buprenorphine can trigger precipitated withdrawal in opioid-dependent individuals due to its partial agonist activity and high receptor affinity, clarifying that naloxone is not responsible for this effect. It appears within the document's broader discussion of buprenorphine’s risks, focusing on tolerance, addiction, and complications associated with withdrawal and drug interactions.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_16", "document_index": 69, "latency_s": 11.338994499994442, "prompt_toks": 5212, "completion_toks": 86}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Dangerous interactions\n\nWarning: Many psychoactive substances that are reasonably safe to use on their own can suddenly become dangerous and even life-threatening when combined with certain other substances. The following list provides some known dangerous interactions (although it is not guaranteed to include all of them).\n\nAlways conduct independent research (e.g. Google, DuckDuckGo, PubMed) to ensure that a combination of two or more substances is safe to consume. Some of the listed interactions have been sourced from TripSit.\n\nAlcohol - Both substances potentiate the ataxia and sedation caused by the other and can lead to unexpected loss of consciousness at high doses. Place affected patients in the recovery position to prevent vomit aspiration from excess. Memory blackouts are likely\n\n\n                    Context: \n                    This section lists dangerous interactions between buprenorphine and other substances, warning that combining it with certain drugs—such as alcohol, depressants, stimulants, or other psychoactives—can greatly increase health risks, including overdose and death. It provides specific examples and emphasizes the importance of independent research for safety, as part of the document's broader harm reduction and safety guidance related to buprenorphine use.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_17", "document_index": 69, "latency_s": 9.132371699990472, "prompt_toks": 5226, "completion_toks": 56}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Stimulants - Stimulants increase respiration rate which allows for a higher dose of opiates than would otherwise be used. If the stimulant wears off first then the opiate may overcome the user and cause respiratory arrest.\n\nBenzodiazepines - Central nervous system and/or respiratory-depressant effects may be additively or synergistically present. The two substances potentiate each other strongly and unpredictably, very rapidly leading to unconsciousness. While unconscious, vomit aspiration is a risk if not placed in the recovery position blackouts/memory loss likely.\n\nDXM - Generally considered to be toxic. CNS depression, difficulty breathing, heart issues, and liver toxicity have been observed. Additionally if one takes DXM, their tolerance of opiates goes down slightly, thus causing additional synergistic effects.\n\n\n                    Context: \n                    This chunk is part of the \"Dangerous interactions\" section, listing specific drug combinations with buprenorphine (such as stimulants, benzodiazepines, and DXM) that can increase health risks, explaining the mechanisms and potential dangers of each interaction.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_18", "document_index": 69, "latency_s": 10.627802600007271, "prompt_toks": 5259, "completion_toks": 83}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    GHB/GBL - The two substances potentiate each other strongly and unpredictably, very rapidly leading to unconsciousness. While unconscious, vomit aspiration is a risk if not placed in the recovery position\n\nKetamine - Both substances bring a risk of vomiting and unconsciousness. If the user falls unconscious while under the influence there is a severe risk of vomit aspiration if they are not placed in the recovery position.\n\nMAOIs - Coadministration of monoamine oxidase inhibitors (MAOIs) with certain opioids has been associated with rare reports of severe adverse reactions. There appear to be two types of interaction, an excitatory and a depressive one. Symptoms of the excitatory reaction may include agitation, headache, diaphoresis, hyperpyrexia, flushing, shivering, myoclonus, rigidity, tremor, diarrhea, hypertension, tachycardia, seizures, and coma. Death has occurred in some cases.\n\n\n                    Context: \n                    This chunk is part of the \"Dangerous interactions\" section, which lists potentially life-threatening drug combinations to avoid when using buprenorphine. It specifically details the heightened risks and adverse effects of combining buprenorphine with GHB/GBL, ketamine, or MAOIs, emphasizing severe outcomes like unpredictable unconsciousness, vomit aspiration, and rare but serious reactions including seizures and coma.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_19", "document_index": 69, "latency_s": 9.942939700005809, "prompt_toks": 5209, "completion_toks": 58}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    MXE - MXE can potentiate the effects of opioids but also increases the risk of respiratory depression and organ toxicity.\n\nNitrous - Both substances potentiate the ataxia and sedation caused by the other and can lead to unexpected loss of consciousness at high doses. While unconscious, vomit aspiration is a risk if not placed in the recovery position. Memory blackouts are common.\n\nPCP - PCP may reduce opioid tolerance, increasing the risk of overdose.\n\nTramadol - Increased risk of seizures. Tramadol itself is known to induce seizures and it may have additive effects on seizure threshold with other opioids. Central nervous system- and/or respiratory-depressant effects may be additively or synergistically present.\n\n\n                    Context: \n                    This chunk appears in the \"Dangerous interactions\" subsection under \"Toxicity and harm potential,\" listing specific substances—MXE, nitrous, PCP, and tramadol—that can dangerously interact with buprenorphine, describing the risks and adverse effects associated with each combination.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_20", "document_index": 69, "latency_s": 10.743132900010096, "prompt_toks": 5275, "completion_toks": 71}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Grapefruit - While grapefruit is not psychoactive, it may affect the metabolism of certain opioids. Tramadol, oxycodone, and fentanyl are all primarily metabolized by the enzyme CYP3A4, which is potently inhibited by grapefruit juice[8]. This may cause the drug to take longer to clear from the body. it may increase toxicity with repeated doses. Methadone may also be affected[8]. Codeine and hydrocodone are metabolized by CYP2D6. People who are on medicines that inhibit CYP2D6, or that lack the enzyme due to a genetic mutation will not respond to codeine as it can not be metabolized into its active product: morphine.\n\nLegal status\n\nThis legality section is a stub . As such, it may contain incomplete or wrong information. You can help by expanding it .\n\nIn the European Union, buprenorphine can be prescribed either alone or in combination with another substance and is approved for the treatment of opioid addiction.[9]\n\n\n                    Context: \n                    This chunk appears in the \"Dangerous interactions\" section of the buprenorphine drug page, detailing how grapefruit can affect the metabolism and toxicity of certain opioids, before transitioning into the beginning of the \"Legal status\" section, which outlines the regulatory status of buprenorphine in the European Union and notes the section's incomplete status.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_21", "document_index": 69, "latency_s": 10.444440399995074, "prompt_toks": 5291, "completion_toks": 53}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    In the European Union, buprenorphine can be prescribed either alone or in combination with another substance and is approved for the treatment of opioid addiction.[9]\n\nAustria: Buprenorphine is legal for medical use under the AMG (Arzneimittelgesetz Österreich) and illegal when sold or possessed without a prescription under the SMG (Suchtmittelgesetz Österreich).[citation needed]\n\nCanada: Buprenorphine is a schedule I substance in Canada and is only available with a valid prescription. [10]\n\nGermany: Buprenorphine is controlled under Anlage III BtMG (Narcotics Act, Schedule III)[11] as of September 1, 1984.[12] It can only be prescribed on a narcotic prescription form.\n\nNetherlands: Buprenorphine a List II drug of the Opium Law, although special rules apply to its prescription and dispensation.[citation needed]\n\nRussia: Buprenorphine is a Schedule II controlled substance.[13]\n\nSweden: Buprenorphine is a class IV controlled substance.[14]\n\n\n                    Context: \n                    This chunk is part of the \"Legal status\" section of the Buprenorphine article, detailing the specific legal classification and prescription regulations for buprenorphine in various countries within the context of its general approval for medical use and treatment of opioid addiction.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_22", "document_index": 69, "latency_s": 9.829970500024501, "prompt_toks": 5161, "completion_toks": 43}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    Russia: Buprenorphine is a Schedule II controlled substance.[13]\n\nSweden: Buprenorphine is a class IV controlled substance.[14]\n\nSwitzerland: Buprenorphine is a controlled substance specifically named under Verzeichnis A. Medicinal use is permitted.[15]\n\nUnited States: Buprenorphine, either alone or in combination with naloxone (as, for example, Suboxone), is a Schedule III drug.[citation needed]\n\n\n                    Context: \n                    This chunk is part of the \"Legal status\" section, listing the regulatory classification of buprenorphine in various countries to inform readers about its medical use, prescription controls, and scheduling under national drug laws.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_23", "document_index": 69, "latency_s": 10.872884399985196, "prompt_toks": 5276, "completion_toks": 79}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    United States: Buprenorphine, either alone or in combination with naloxone (as, for example, Suboxone), is a Schedule III drug.[citation needed]\n\nPrior to the approval of Suboxone in the U.S. for treating opioid addiction, the Drug Addiction Treatment Act of 2000 was passed. This law gives the Secretary of Health and Human Services the authority to grant a waiver to all physicians with appropriate training to prescribe and administer narcotics from Schedules III-V in the treatment of drug addiction. Prior to the passage of this law such authority was restricted solely to physicians working in an outpatient clinic specifically designed for treatment of addiction. The waiver, which requires the physician to undergo an 8-hour training course, initially allowed that physician to treat only 10 patients in this manner; as of 2016, this limit has been increased to 275.[16]\n\nSee also\n\nResponsible use\n\nDepressants\n\nOxycodone\n\nKratom\n\nExternal links\n\nBuprenorphine (Wikipedia)\n\n\n                    Context: \n                    This section appears within the \"Legal status\" portion of the document, detailing the regulatory status and prescribing practices for buprenorphine in the United States, including its classification as a Schedule III drug, the requirements for physician waivers under the Drug Addiction Treatment Act of 2000, patient limits, and relevant legal developments. It immediately precedes the \"See also\" and external resources sections.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_24", "document_index": 69, "latency_s": 10.750791200000094, "prompt_toks": 5388, "completion_toks": 76}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    See also\n\nResponsible use\n\nDepressants\n\nOxycodone\n\nKratom\n\nExternal links\n\nBuprenorphine (Wikipedia)\n\nBuprenorphine (Erowid Vault)\n\nBuprenorphine (Isomer Design)\n\nBuprenorphine (DrugBank)\n\nBuprenorphine (Drugs.com)\n\nBuprenorphine (Drugs-Forum)\n\nReferences\n\n↑ Risks of Combining Depressants - TripSit\n\n↑ Mendelson, J., Upton, R. A., Everhart, E. T., Jacob, P., Jones, R. T. (January 1997). \"Bioavailability of sublingual buprenorphine\". Journal of Clinical Pharmacology. 37 (1): 31–37. doi:10.1177/009127009703700106. ISSN 0091-2700.\n\n↑ Eriksen, J., Jensen, N. H., Kamp-Jensen, M., Bjarnø, H., Friis, P., Brewster, D. (November 1989). \"The systemic availability of buprenorphine administered by nasal spray\". The Journal of Pharmacy and Pharmacology. 41 (11): 803–805. doi:10.1111/j.2042-7158.1989.tb06374.x. ISSN 0022-3573.\n\n↑ Fischer, J., Ganellin, C. R. (2006). Analogue-based drug discovery. Wiley-VCH. ISBN 9783527607495.\n\n\n                    Context: \n                    This chunk appears at the end of the buprenorphine article, following the main content sections on chemistry, pharmacology, effects, harm potential, and legal status. It provides supplemental navigation and resources, including related topics under \"See also,\" a list of \"External links\" for further reading, and the beginning of the reference list that cites sources used throughout the document.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_25", "document_index": 69, "latency_s": 10.580463499994949, "prompt_toks": 5327, "completion_toks": 74}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    ↑ Fischer, J., Ganellin, C. R. (2006). Analogue-based drug discovery. Wiley-VCH. ISBN 9783527607495.\n\n↑ 5.0 5.1 5.2 Buprenorphine, Substance Abuse and Mental Health Services Administration, retrieved July 29, 2019\n\n↑ Nutt DJ, King LA, Phillips LD (November 2010). \"Drug harms in the UK: a multicriteria decision analysis\". Lancet. 376 (9752): 1558–1565. CiteSeerX 10.1.1.690.1283 . doi:10.1016/S0140-6736(10)61462-6. PMID 21036393. Unknown parameter |s2cid= ignored (help)\n\n↑ Nutt D, King LA, Saulsbury W, Blakemore C (March 2007). \"Development of a rational scale to assess the harm of drugs of potential misuse\". Lancet. 369 (9566): 1047–1053. doi:10.1016/S0140-6736(07)60464-4. PMID 17382831. Unknown parameter |s2cid= ignored (help)\n\n\n                    Context: \n                    This chunk appears in the References section of a comprehensive article on buprenorphine, following detailed information on its chemistry, pharmacology, effects, toxicity, harm potential, and legal status. The listed references support key claims and data presented throughout the document, particularly regarding drug discovery, drug harms assessment, and official sources on buprenorphine use and regulation.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_26", "document_index": 69, "latency_s": 10.171740399993723, "prompt_toks": 5404, "completion_toks": 55}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    ↑ 8.0 8.1 Ershad, M., Cruz, M. D., Mostafa, A., Mckeever, R., Vearrier, D., Greenberg, M. I. (March 2020). \"Opioid Toxidrome Following Grapefruit Juice Consumption in the Setting of Methadone Maintenance\". Journal of Addiction Medicine. 14 (2): 172–174. doi:10.1097/ADM.0000000000000535. ISSN 1932-0620.\n\n↑ EMA (2018), Suboxone\n\n↑ Consolidated federal laws of Canada, Controlled Drugs and Substances Act, 2022\n\n↑ \"Anlage III BtMG\" (in German). Bundesministerium der Justiz und für Verbraucherschutz. Retrieved December 18, 2019.\n\n↑ \"Erste Verordnung zur Änderung betäubungsmittelrechtlicher Vorschriften\" (PDF). Bundesgesetzblatt Jahrgang 1984 Teil I Nr. 36 (in German). Bundesanzeiger Verlag. August 8, 1984. Retrieved December 18, 2019.\n\n↑ Постановление Правительства РФ от 01.10.2012 N 1002 (ред. от 09.08.2019)\n\n↑ Läkemedelsverkets föreskrifter (LVFS 1997:12) om förteckningar över narkotika, konsoliderad version t.o.m. LVFS 2010:1\n\n\n                    Context: \n                    This chunk is part of the references section at the end of the buprenorphine article, providing source citations for statements about grapefruit interactions, Suboxone regulation, legal status in Canada, Germany, Russia, Sweden, and related topics discussed in the main text.\n                "}
{"metadata": {"source": "psychonaut", "title": "Buprenorphine - PsychonautWiki", "description": "Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/Buprenorphine", "drug": "Buprenorphine", "cid": 644073, "char_count": 20384, "word_count": 2974, "doc_id": "doc_69", "chunk_id": "69::chunk_27", "document_index": 69, "latency_s": 10.7434845000098, "prompt_toks": 5268, "completion_toks": 53}, "content": "Drug: Buprenorphine | cid: 644073\nSource: psychonaut | Source description: Buprenorphine is a semisynthetic opioid of the morphinan chemical class. It functions as a mixed partial agonist opioid receptor modulator.\n\n                    Text: \n                    ↑ Постановление Правительства РФ от 01.10.2012 N 1002 (ред. от 09.08.2019)\n\n↑ Läkemedelsverkets föreskrifter (LVFS 1997:12) om förteckningar över narkotika, konsoliderad version t.o.m. LVFS 2010:1\n\n↑ \"Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien\" (in German). Bundeskanzlei [Federal Chancellery of Switzerland]. Retrieved January 1, 2020.\n\n↑ Jacobs, H., The Obama administration made a change that could have a huge effect on the opioid epidemic\n\nRetrieved from ‘https://psychonautwiki.org/w/index.php?title=Buprenorphine&oldid=165586’\n\n\n                    Context: \n                    This chunk appears in the \"References\" section of the Buprenorphine article, listing sources related to the drug's legal status in Russia, Sweden, Switzerland, and U.S. policy changes, as well as citing the article's original URL for verification.\n                "}
